The genetic defect causing familial Alzheimer's disease maps on chromosome 21.

PubWeight™: 3.59‹?› | Rank: Top 1%

🔗 View Article (PMID 2880399)

Published in Science on February 20, 1987

Authors

P H St George-Hyslop, R E Tanzi, R J Polinsky, J L Haines, L Nee, P C Watkins, R H Myers, R G Feldman, D Pollen, D Drachman

Articles citing this

(truncated to the top 100)

Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. Am J Hum Genet (1991) 4.19

Genetic linkage map of human chromosome 7 with 63 DNA markers. Proc Natl Acad Sci U S A (1987) 2.91

Would decreased aluminum ingestion reduce the incidence of Alzheimer's disease? CMAJ (1991) 2.58

Biomarker modeling of Alzheimer's disease. Neuron (2013) 2.51

Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease. Alzheimers Res Ther (2011) 2.51

Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques. Am J Pathol (1988) 2.42

Cloning and chromosomal localization of human genes encoding the three chains of type VI collagen. Am J Hum Genet (1988) 2.34

The genetics of Alzheimer disease. Cold Spring Harb Perspect Med (2012) 2.20

Neuronal localization of amyloid beta protein precursor mRNA in normal human brain and in Alzheimer's disease. EMBO J (1987) 2.16

A genomewide screen for schizophrenia genes in an isolated Finnish subpopulation, suggesting multiple susceptibility loci. Am J Hum Genet (1999) 2.15

Genetics of Alzheimer's disease: a centennial review. Neurol Clin (2007) 1.93

Feature article: Recombinant DNA technology, genetic tests, and public policy. Am J Hum Genet (1988) 1.90

Genetics, transcriptomics, and proteomics of Alzheimer's disease. J Clin Psychiatry (2006) 1.81

Identification and regional localization of DNA markers on chromosome 7 for the cloning of the cystic fibrosis gene. Am J Hum Genet (1988) 1.80

Genetics, chance, and morphogenesis. Am J Hum Genet (1987) 1.76

Linkage analysis of 49 high-risk families does not support a common familial prostate cancer-susceptibility gene at 1q24-25. Am J Hum Genet (1997) 1.68

Age associated memory impairment. BMJ (1992) 1.54

Physical mapping around the Alzheimer disease locus on the proximal long arm of chromosome 21. Am J Hum Genet (1990) 1.49

Apolipoprotein E and Alzheimer's disease: the implications of progress in molecular medicine. Am J Public Health (1995) 1.46

Differential regulation of amyloid-beta-protein mRNA expression within hippocampal neuronal subpopulations in Alzheimer disease. Proc Natl Acad Sci U S A (1988) 1.43

Review and hypothesis: Alzheimer disease and Down syndrome--chromosome 21 nondisjunction may underlie both disorders. Am J Hum Genet (1991) 1.43

Genetic dissection of Alzheimer disease, a heterogeneous disorder. Proc Natl Acad Sci U S A (1995) 1.40

Assessment of amyloid beta-protein precursor gene mutations in a large set of familial and sporadic Alzheimer disease cases. Am J Hum Genet (1992) 1.37

A genetic linkage map of human chromosome 21: analysis of recombination as a function of sex and age. Am J Hum Genet (1992) 1.36

Partial trisomy chromosome 5 cosegregating with schizophrenia. Lancet (1988) 1.35

Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play. Radiology (2012) 1.34

Does Alzheimer's disease begin in the brainstem? Neuropathol Appl Neurobiol (2009) 1.26

Linkage analysis of familial Alzheimer disease, using chromosome 21 markers. Am J Hum Genet (1991) 1.26

A multilocus extension of the affected-pedigree-member method of linkage analysis. Am J Hum Genet (1992) 1.26

Segregation analysis reveals evidence of a major gene for Alzheimer disease. Am J Hum Genet (1991) 1.25

Genomewide scan for familial combined hyperlipidemia genes in finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels. Am J Hum Genet (1999) 1.21

Simulation of Mendelism revisited: the recessive gene for attending medical school. Am J Hum Genet (1990) 1.19

The gene for cystathionine beta-synthase (CBS) maps to the subtelomeric region on human chromosome 21q and to proximal mouse chromosome 17. Am J Hum Genet (1988) 1.18

Genetics of Alzheimer disease in the pre- and post-GWAS era. Alzheimers Res Ther (2010) 1.18

Parenchymal and vascular Abeta-deposition and its effects on the degeneration of neurons and cognition in Alzheimer's disease. J Cell Mol Med (2008) 1.16

Down's syndrome, neuroinflammation, and Alzheimer neuropathogenesis. J Neuroinflammation (2013) 1.16

Age-related changes in the density and morphology of plaques and neurofibrillary tangles in Down syndrome brain. Acta Neuropathol (1989) 1.16

Chasing genes in Alzheimer's and Parkinson's disease. Hum Genet (2004) 1.11

The genetic landscape of Alzheimer disease: clinical implications and perspectives. Genet Med (2015) 1.09

Novel beta-secretase cleavage of beta-amyloid precursor protein in the endoplasmic reticulum/intermediate compartment of NT2N cells. J Cell Biol (1997) 1.07

APP717, APP693, and PRIP gene mutations are rare in Alzheimer disease. Am J Hum Genet (1991) 1.06

The genomically mosaic brain: aneuploidy and more in neural diversity and disease. Semin Cell Dev Biol (2013) 1.05

The future of genetic research on neurodegeneration. Nat Med (2010) 1.04

Translational research on the way to effective therapy for Alzheimer disease. Arch Gen Psychiatry (2005) 1.03

Epigenomics of Alzheimer's disease. Transl Res (2014) 1.01

A genome-wide linkage analysis of dementia in the Amish. Am J Med Genet B Neuropsychiatr Genet (2006) 1.00

Antioxidant therapy in Alzheimer's disease: theory and practice. Mini Rev Med Chem (2008) 1.00

On the promise of pharmacotherapies targeted at cognitive and neurodegenerative components of Down syndrome. Dev Neurosci (2011) 0.99

Chromosome 14 and late-onset familial Alzheimer disease (FAD). Am J Hum Genet (1993) 0.98

Presenile dementia syndromes: an update on taxonomy and diagnosis. J Neurol Neurosurg Psychiatry (2002) 0.95

Molecular consequences of amyloid precursor protein and presenilin mutations causing autosomal-dominant Alzheimer's disease. Alzheimers Res Ther (2012) 0.95

Chromosomal aberrations and schizophrenia. Autosomes. Br J Psychiatry (1992) 0.93

Genomic mosaicism with increased amyloid precursor protein (APP) gene copy number in single neurons from sporadic Alzheimer's disease brains. Elife (2015) 0.93

Medicine in the elderly. Postgrad Med J (1991) 0.93

Genetic fatalism and social policy: the implications of behavior genetics research. Yale J Biol Med (1995) 0.92

Molecular genetics of human chromosome 21. J Med Genet (1987) 0.90

A potential role for alterations of zinc and zinc transport proteins in the progression of Alzheimer's disease. J Alzheimers Dis (2009) 0.90

The role of phenotype in gene discovery in the whole genome sequencing era. Hum Genet (2012) 0.89

Regulatory region of human amyloid precursor protein (APP) gene promotes neuron-specific gene expression in the CNS of transgenic mice. EMBO J (1991) 0.88

Combinatorial Mismatch Scan (CMS) for loci associated with dementia in the Amish. BMC Med Genet (2006) 0.88

Familial 5q11.2----q13.3 segmental duplication cosegregating with multiple anomalies, including schizophrenia. Am J Med Genet (1990) 0.87

The genetics of Alzheimer disease--a teasing problem. Am J Hum Genet (1991) 0.87

Neuroinflammatory Cytokines-The Common Thread in Alzheimer's Pathogenesis. US Neurol (2010) 0.86

LRP in Alzheimer's disease: friend or foe? J Clin Invest (2000) 0.85

The genetic epidemiology of schizophrenia and the design of linkage studies. Eur Arch Psychiatry Clin Neurosci (1991) 0.85

A contiguous Not I restriction map of band q22.3 of human chromosome 21. Proc Natl Acad Sci U S A (1992) 0.85

The impact of the human genome project on complex disease. Genes (Basel) (2014) 0.85

Combating neurodegenerative disease with chemical probes and model systems. Nat Chem Biol (2014) 0.85

Detection of marker associations with a dominant disease gene in genetically complex and heterogeneous diseases. Am J Hum Genet (1989) 0.85

Genetics of gene expression in CNS. Int Rev Neurobiol (2014) 0.84

Racial differences in the etiology of dementia and frequency of Alzheimer lesions in the brain. J Natl Med Assoc (1989) 0.84

Familial Alzheimer's disease: second gene locus located. BMJ (1992) 0.84

Isolation, characterization, and regional mapping of microclones from a human chromosome 21 microdissection library. Am J Hum Genet (1992) 0.83

Analysis of chromosome 21 yeast artificial chromosome (YAC) clones. Am J Hum Genet (1992) 0.83

Regional assignment of six polymorphic DNA sequences on chromosome 21 by in situ hybridization to normal and rearranged chromosomes. Am J Hum Genet (1988) 0.83

Alzheimer's disease: pathophysiology and applications of magnetic nanoparticles as MRI theranostic agents. ACS Chem Neurosci (2013) 0.82

Aggregation, impaired degradation and immunization targeting of amyloid-beta dimers in Alzheimer's disease: a stochastic modelling approach. Mol Neurodegener (2012) 0.82

A genotype-phenotype research strategy for schizophrenia. Can J Psychiatry (1990) 0.82

Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies. Biomolecules (2016) 0.81

Specific Silencing of L392V PSEN1 Mutant Allele by RNA Interference. Int J Alzheimers Dis (2011) 0.81

Neuroinflammation and tumor necrosis factor signaling in the pathophysiology of Alzheimer's disease. J Inflamm Res (2008) 0.81

Biological function of Presenilin and its role in AD pathogenesis. Transl Neurodegener (2013) 0.81

Comparative map for mice and humans. Mamm Genome (1991) 0.81

Gene mutations in inherited amyloidopathies of the nervous system. Am J Hum Genet (1991) 0.80

Alzheimer's disease. Postgrad Med J (1992) 0.80

Memory and neurogenesis in aging and Alzheimer's disease. Aging Dis (2010) 0.80

Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer's Disease Phenotypes. PLoS One (2016) 0.79

Down's syndrome fibroblasts exhibit enhanced inositol uptake. Biochem J (1990) 0.79

Recent research on the causes of Alzheimer's disease. BMJ (1988) 0.79

Amyloid-precursor-protein-lowering small molecules for disease modifying therapy of Alzheimer's disease. PLoS One (2013) 0.78

A contribution to the differential diagnosis of the "group of schizophrenias": structural abnormality of chromosome 4. J Psychiatry Neurosci (1994) 0.78

Development of a novel cellular model of Alzheimer's disease utilizing neurosphere cultures derived from B6C3-Tg(APPswe,PSEN1dE9)85Dbo/J embryonic mouse brain. Springerplus (2014) 0.78

Down's syndrome and the links with Alzheimer's disease. J Neurol Neurosurg Psychiatry (1995) 0.78

Familial dementia with frontotemporal features associated with M146V presenilin-1 mutation. Brain Pathol (2013) 0.78

Identification and modification of amyloid-independent phenotypes of APOE4 mice. Exp Neurol (2016) 0.77

Alzheimer disease: the new agenda. Am J Hum Genet (1992) 0.77

Bacterial contig map of the 21q11 region associated with Alzheimer's disease and abnormal myelopoiesis in Down syndrome. Genome Res (1998) 0.77

Rare Variants and Transcriptomics in Alzheimer disease. Curr Genet Med Rep (2014) 0.76

Linkage analysis of infantile pyloric stenosis and markers from chromosome 9q11-q33: no evidence for a major gene in this candidate region. J Med Genet (1993) 0.76

The genetics of Alzheimer's disease. Scientifica (Cairo) (2012) 0.76

Articles by these authors

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science (1993) 33.32

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA (1997) 17.88

A polymorphic DNA marker genetically linked to Huntington's disease. Nature (1984) 16.71

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature (1995) 13.80

Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science (2009) 13.45

Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46

Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the framingham heart study. Hypertension (2000) 8.84

Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science (1987) 8.29

Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol (1985) 7.93

Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat Genet (1998) 7.26

Rapid induction of Alzheimer A beta amyloid formation by zinc. Science (1994) 5.34

Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron (2001) 4.42

CAG repeat number governs the development rate of pathology in Huntington's disease. Ann Neurol (1997) 4.01

Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. JAMA (1997) 4.00

Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology (2005) 3.90

A highly polymorphic locus very tightly linked to the Huntington's disease gene. Nature (1988) 3.90

Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation (1998) 3.89

Predictive testing for Huntington's disease with use of a linked DNA marker. N Engl J Med (1988) 3.82

The 'subcortical dementia' of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry (1974) 3.48

Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity. N Engl J Med (1991) 3.45

Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science (2000) 3.16

CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology (2012) 3.12

Localization of the Huntington's disease gene to a small segment of chromosome 4 flanked by D4S10 and the telomere. Cell (1987) 3.11

An autosomal genomic screen for autism. Collaborative linkage study of autism. Am J Med Genet (1999) 3.07

ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative. Neurology (1997) 3.04

DNA markers for nervous system diseases. Science (1984) 3.02

Isolation of polymorphic DNA fragments from human chromosome 4. Nucleic Acids Res (1987) 2.83

Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder. Nature (1990) 2.80

Complete genomic screen in Parkinson disease: evidence for multiple genes. JAMA (2001) 2.79

Head drop and camptocormia. J Neurol Neurosurg Psychiatry (2002) 2.78

Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis. J Biol Chem (1998) 2.78

Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol (1991) 2.70

A gene responsible for the pigment dispersion syndrome maps to chromosome 7q35-q36. Arch Ophthalmol (1997) 2.64

A DNA segment encoding two genes very tightly linked to Huntington's disease. Science (1987) 2.63

The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry (1999) 2.58

Genetics of aging. Science (1997) 2.57

Genetic and environmental contributions to platelet aggregation: the Framingham heart study. Circulation (2001) 2.54

Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis. Neurology (2004) 2.50

Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N Engl J Med (1996) 2.49

Rate of functional decline in Huntington's disease. Huntington Study Group. Neurology (2000) 2.49

Regional localization of DNA sequences on chromosome 21 using somatic cell hybrids. Am J Hum Genet (1986) 2.45

Evidence for a Mendelian gene in a segregation analysis of generalized radiographic osteoarthritis: the Framingham Study. Arthritis Rheum (1998) 2.45

The clinical introduction of genetic testing for Alzheimer disease. An ethical perspective. JAMA (1997) 2.45

Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nat Med (1996) 2.43

Homozygotes for Huntington's disease. Nature (1987) 2.40

Paraoxonase cluster polymorphisms are associated with sporadic ALS. Neurology (2006) 2.38

LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted beta-amyloid precursor protein and mediates its degradation. Cell (1995) 2.37

Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease. JAMA (2001) 2.36

Head injury and the risk of AD in the MIRAGE study. Neurology (2000) 2.34

Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands. Nat Med (2000) 2.34

Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22. Nature (1987) 2.32

Prediction of probable Alzheimer's disease in memory-impaired patients: A prospective longitudinal study. Neurology (1996) 2.31

Increased rate of suicide among patients with Huntington's disease. J Neurol Neurosurg Psychiatry (1984) 2.31

Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. J Biol Chem (1999) 2.30

Mapping, cloning and genetic characterization of the region containing the Wilson disease gene. Nat Genet (1993) 2.29

Effect of L-dopa on plasma homocysteine in PD patients: relationship to B-vitamin status. Neurology (2003) 2.28

Evidence for reduced recombination on the nondisjoined chromosomes 21 in Down syndrome. Science (1987) 2.27

Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. Hum Mol Genet (1998) 2.26

Occupational lead neurotoxicity: a behavioural and electrophysiological evaluation. Study design and year one results. Br J Ind Med (1984) 2.26

Clustering of multiallele DNA markers near the Huntington's disease gene. J Clin Invest (1989) 2.25

Presenilin-mediated modulation of capacitative calcium entry. Neuron (2000) 2.25

Deletion of Huntington's disease-linked G8 (D4S10) locus in Wolf-Hirschhorn syndrome. Nature (1985) 2.19

Studies of a DNA marker (G8) genetically linked to Huntington disease in British families. Hum Genet (1986) 2.18

Molecular genetic approach to the characterization of the "Down syndrome region" of chromosome 21. Genomics (1989) 2.16

Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study. Neurology (2008) 2.16

Neonatal pulmonary hypertension--urea-cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function. N Engl J Med (2001) 2.16

Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease. Am J Med Genet A (2003) 2.15

Rapid detection of human chromosome 21 aberrations by in situ hybridization. Proc Natl Acad Sci U S A (1988) 2.15

Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21-q22. JAMA (2000) 2.08

Wiedemann-Beckwith syndrome: presentation of clinical and cytogenetic data on 22 new cases and review of the literature. Hum Genet (1986) 2.07

Critical role of the D21S55 region on chromosome 21 in the pathogenesis of Down syndrome. Proc Natl Acad Sci U S A (1989) 2.06

Aetiology of urinary symptoms in sexually active women. Genitourin Med (1986) 2.03

HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. Am J Hum Genet (2003) 2.02

An alpha-2-macroglobulin insertion-deletion polymorphism in Alzheimer disease. Nat Genet (1999) 2.01

Modulation of beta-amyloid precursor protein processing by the low density lipoprotein receptor-related protein (LRP). Evidence that LRP contributes to the pathogenesis of Alzheimer's disease. J Biol Chem (2000) 2.00

Hyperkalemic periodic paralysis and the adult muscle sodium channel alpha-subunit gene. Science (1990) 1.99

Hereditary spherocytosis associated with deletion of human erythrocyte ankyrin gene on chromosome 8. Nature (1990) 1.99

Rapid and efficient cloning of Alu-PCR products using uracil DNA glycosylase. PCR Methods Appl (1991) 1.96

Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the amyloid beta-peptide. Nat Cell Biol (2001) 1.96

Genetic associations in age-related hearing thresholds. Arch Otolaryngol Head Neck Surg (1999) 1.94

Evidence for a gene influencing the TG/HDL-C ratio on chromosome 7q32.3-qter: a genome-wide scan in the Framingham study. Hum Mol Genet (2000) 1.94

Factors related to onset age of Huntington disease. Am J Hum Genet (1982) 1.93

Alzheimer's disease: genetic studies and transgenic models. Annu Rev Genet (1998) 1.93

Epidemiologic study of 203 sibling pairs with Parkinson's disease: the GenePD study. Neurology (2002) 1.90

Genome-wide association study of Alzheimer's disease. Transl Psychiatry (2012) 1.88